Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Celldex Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Celldex Therapeutics Inc.
Rating: 1.64775
Author: Trendlyne DVM scores

about

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

22.87 0.09 (0.40%)

51.34% Fall from 52W High

1.1M

XNAS Volume

XNAS 05 Sep, 2025 4:11 PM (EDT)

Not Eligible

Expensive Valuation

8.0 / 100

Technically Neutral

57.9 / 100

1Yr Price target upside is 143%

13 analysts

Celldex Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Celldex Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

51.34% Fall from 52W High

SWOT Analysis

Celldex Therapeutics Inc Live Price Chart